SK281867B6 - Deriváty 3,3a,4,5-tetrahydro-1h-oxazolo[3,4-a]chinolin-1-ónu, spôsob ich prípravy, liečivo a farmaceutický prostriedok obsahujúce tieto deriváty - Google Patents

Deriváty 3,3a,4,5-tetrahydro-1h-oxazolo[3,4-a]chinolin-1-ónu, spôsob ich prípravy, liečivo a farmaceutický prostriedok obsahujúce tieto deriváty Download PDF

Info

Publication number
SK281867B6
SK281867B6 SK1089-95A SK108995A SK281867B6 SK 281867 B6 SK281867 B6 SK 281867B6 SK 108995 A SK108995 A SK 108995A SK 281867 B6 SK281867 B6 SK 281867B6
Authority
SK
Slovakia
Prior art keywords
tetrahydro
quinolin
oxazolo
formula
group
Prior art date
Application number
SK1089-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK108995A3 (en
Inventor
Samir Jegham
Jean Jacques Koenig
Fr�D�Ric Puech
Philippe Burnier
Lydia Zard
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK108995A3 publication Critical patent/SK108995A3/sk
Publication of SK281867B6 publication Critical patent/SK281867B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Quinoline Compounds (AREA)
SK1089-95A 1994-09-05 1995-09-04 Deriváty 3,3a,4,5-tetrahydro-1h-oxazolo[3,4-a]chinolin-1-ónu, spôsob ich prípravy, liečivo a farmaceutický prostriedok obsahujúce tieto deriváty SK281867B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
SK108995A3 SK108995A3 (en) 1996-06-05
SK281867B6 true SK281867B6 (sk) 2001-08-06

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1089-95A SK281867B6 (sk) 1994-09-05 1995-09-04 Deriváty 3,3a,4,5-tetrahydro-1h-oxazolo[3,4-a]chinolin-1-ónu, spôsob ich prípravy, liečivo a farmaceutický prostriedok obsahujúce tieto deriváty

Country Status (28)

Country Link
US (1) US5641785A (no)
EP (1) EP0699680B1 (no)
JP (1) JP4225585B2 (no)
KR (1) KR100392523B1 (no)
CN (1) CN1055472C (no)
AT (1) ATE190311T1 (no)
AU (1) AU687591B2 (no)
CA (1) CA2157427C (no)
CZ (1) CZ286128B6 (no)
DE (1) DE69515402T2 (no)
DK (1) DK0699680T3 (no)
ES (1) ES2145886T3 (no)
FI (1) FI110945B (no)
FR (1) FR2724171B1 (no)
GR (1) GR3033554T3 (no)
HK (1) HK1013652A1 (no)
HU (1) HU218587B (no)
IL (1) IL115276A (no)
NO (1) NO306617B1 (no)
NZ (1) NZ272920A (no)
PL (1) PL184412B1 (no)
PT (1) PT699680E (no)
RU (1) RU2141482C1 (no)
SI (1) SI0699680T1 (no)
SK (1) SK281867B6 (no)
TW (1) TW356467B (no)
UA (1) UA41916C2 (no)
ZA (1) ZA957414B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
WO2005090309A1 (en) * 2004-03-12 2005-09-29 Wyeth 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
AU2008226649B2 (en) * 2007-03-09 2013-08-01 Sanofi Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
NO953458L (no) 1996-03-06
IL115276A (en) 1998-12-06
EP0699680B1 (fr) 2000-03-08
AU3041595A (en) 1996-03-21
US5641785A (en) 1997-06-24
JPH0899881A (ja) 1996-04-16
SI0699680T1 (en) 2000-10-31
NO953458D0 (no) 1995-09-04
PL310273A1 (en) 1996-03-18
NO306617B1 (no) 1999-11-29
GR3033554T3 (en) 2000-09-29
PT699680E (pt) 2000-08-31
HU9502578D0 (en) 1995-11-28
PL184412B1 (pl) 2002-10-31
TW356467B (en) 1999-04-21
CZ286128B6 (cs) 2000-01-12
CN1128763A (zh) 1996-08-14
UA41916C2 (uk) 2001-10-15
FR2724171B1 (fr) 1997-01-03
FI954141A (fi) 1996-03-06
HU218587B (hu) 2000-10-28
FI954141A0 (fi) 1995-09-04
EP0699680A1 (fr) 1996-03-06
FR2724171A1 (fr) 1996-03-08
JP4225585B2 (ja) 2009-02-18
DE69515402D1 (de) 2000-04-13
IL115276A0 (en) 1996-01-19
AU687591B2 (en) 1998-02-26
HK1013652A1 (en) 1999-09-03
HUT73435A (en) 1996-07-29
ES2145886T3 (es) 2000-07-16
RU2141482C1 (ru) 1999-11-20
CN1055472C (zh) 2000-08-16
FI110945B (fi) 2003-04-30
ZA957414B (en) 1996-04-15
CA2157427A1 (en) 1996-03-06
CA2157427C (en) 2010-06-01
CZ226295A3 (en) 1996-03-13
KR100392523B1 (ko) 2003-11-12
NZ272920A (en) 1998-03-25
DE69515402T2 (de) 2000-10-19
SK108995A3 (en) 1996-06-05
ATE190311T1 (de) 2000-03-15
KR960010648A (ko) 1996-04-20
DK0699680T3 (da) 2000-08-21

Similar Documents

Publication Publication Date Title
SK165795A3 (en) 3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives
US4963558A (en) Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS disorders
EP0033767A1 (en) Indolobenzoxazines, processes for preparing and pharmaceutical compositions containing the same
SK281867B6 (sk) Deriváty 3,3a,4,5-tetrahydro-1h-oxazolo[3,4-a]chinolin-1-ónu, spôsob ich prípravy, liečivo a farmaceutický prostriedok obsahujúce tieto deriváty
EP0126654B1 (en) Tetrahydroisoxazolo(4,5-c)pyridine derivatives and preparation thereof
FR2753970A1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
EP1175417B1 (en) Substituted benzolactam compounds
US5258384A (en) S-11-hydroxy-10-methylaporphine and its biologically active salt forms as 5HT1A inhibitors
US4960769A (en) 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-c]-azepine derivatives
CZ211094A3 (en) Naphthoxazines, process of their preparation, their use as medicaments and pharmaceutical compositions containing those naphthoxazines
EP0302787A1 (fr) Dérivés de (pipéridinyl-4)méthyl-2 benzofuro[2,3-c]pyridines, leur préparation et leur application en thérapeutique
FR2750427A1 (fr) Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
WO1996020927A1 (en) DIBENZ[cd,f]INDOLE DERIVATIVES
FR2737206A1 (fr) Derives d'oxazoloquinoleinone, leur preparation et leur application en therapeutique
SK280546B6 (sk) Deriváty kyseliny 8-oxo-5,8-dihydro-6h-dibenzo[a,g
CA2059142A1 (en) 11-hydroxyaporphines and their biologically active salt forms as 5-ht1a inhibitors
FR2630113A2 (fr) Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
LT3421B (en) Azaspiroalkane derivatives,processes for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20150904